NAMUBIRU UPDATES: Arrested Singer Iryn Namubiru Transferred From Airport Detention Room to Central Tokyo Police Station as Her Promoter is Reported to Have Fled Japan for Home

8th, May 2013
STILL DETAINED: Namubiru with the type of drug she is accused of carrying

Iryn Namubiru has been transferred from the Tokyo airport detention facility to a police station in Central Tokyo where she recorded a statement in connection to the possession of 2kg of MDMA.

MDMA, commonly known as “Ecstasy” is a banned drug in many countries. The drug Iryn was caught with is estimated to be worth USD400,000 (street value). Being in possession of this drug is a crime in Japan.

Iryn Namubiru, in her police statement, denied any knowledge of the drug and said she does not know who it belonged to. Instead she blamed her brother who is also her manager; Thadeus Mubiru for the mishap, a claim that Police rubbished saying it’s a common excuse known culprits always give when caught.

Police said they are treating Iryn Namubiru as a prime suspect until proven otherwise. Iryn faces between 5 to 10 years in jail, and a fine of up to five million Japanese Yen or a deportation to serve the sentence in home country, if she is found guilty.

Meanwhile, the Japan based Uganda promoter who was supposed to receive Iryn at the airport has reportedly fled Japan after getting information that Police was hunting for him as well. The promoter called Kiim Ueno hails from Western Uganda and is rumored to have jetted into Uganda where he is allegedly hiding.

He married a Japanese wife and changed his name to Ueno. Sources to the Investigator also reveal that Iryn Namubiru managed to make contacts with the French Consulate in Japan seeking for help. She holds French citizenship which she acquired after marrying estranged French husband who is also father to her kids.


MDMA (3, 4-methylenedioxy-N-methylamphetamine) is a pathogenic drug of the phenethylamine and amphetamine classes of drugs. MDMA has become widely known as "ecstasy" (shortened to "E", "X", or "XTC"), usually referring to its street pill form, although this term may also include the presence of possible adulterants. The term "molly" or "Mandy" colloquially refers to MDMA in powder or crystalline form, usually implying a higher level of purity.

MDMA can induce euphoria, a sense of intimacy with others, and diminished anxiety. Many studies, particularly in the fields of psychology and cognitive therapy, have suggested that MDMA has therapeutic benefits and facilitates therapy sessions in certain individuals, a practice for which it had formally been used in the past. Clinical trials are now testing the therapeutic potential of MDMA for post-traumatic stress disorder (PTSD) and anxiety associated with terminal cancer.

MDMA is criminalized in most countries and its possession, manufacture, or sale may result in criminal prosecution. Some limited exceptions exist for scientific and medical research. In 2012 the UN estimated between 10–25 million people globally used MDMA at least once. This was broadly similar to the number of cocaine, amphetamine and opioid users, but far fewer than the global number of cannabis users. It is taken in a variety of contexts far removed from its roots in psychotherapeutic settings and is commonly associated with dance parties or music concerts

Recreational use

MDMA is occasionally known for being taken in conjunction with psychedelic drugs, such as LSD or psilocybin mushrooms, or even common drugs such as cannabis. As this practice has become more prevalent, most of the more common combinations have been given nicknames, such as "candy flipping" for MDMA combined with LSD, "hippy flipping" for MDMA with psilocybin mushrooms, or "kitty flipping" for MDMA with ketamine.


The primary subjective effects attributable to MDMA consumption are predictable and fairly consistent among users. In general, users begin reporting subjective effects within 30–60 minutes of consumption, hitting a peak at approximately 75–120 minutes, reaching a plateau that lasts about 3.5 hours.

This is followed by a comedown of a few hours. After the drug has run its course, many users report feeling fatigue, decreolization, depersonalization, altered perception of space and time, positive basic mood, mania-like experience, anxious decreolization, thought disorder, fears of loss of thought or body control, visual hallucinations or pseudo-hallucinations, synesthesia, changed meaning of percepts, facilitated recollection or imagination.

On an Adjective Mood rating scale, the following significantly increase: self-confidence, heightened mood, apprehension-anxiety, thoughtfulness-contemplativeness, extroversion, dazed state, sensitivity and emotional excitation.



More Picture(s)

Drop a comment please.


Follow Us